Shares of Tesaro (TSRO) jumped in late day trading after Bloomberg said the company is working with advisers to explore a possible sale after receiving takeover interest.
Following the report, Tesaro shares rose $2.58, or 9.7%, to $29.17. Clovis Oncology (CLVS), which markets Rubraca, a competitor to Tesaro’s Zejula, gained 9% following the report as well.
User rating: 0.00% ( 0 
The Complete List Of Wilshire 5000 Stocks
Future Market Returns = Dividend Yield + Earnings Growth +/- Change In P/E Ratio
USD/JPY Making A Bullish N Pattern Through Chuvashov Fork
Ebay Rises As Morgan Stanley Double Upgrades On Payments Shakeup
The Pension Crisis Gets A Catchy Name: “Silver Tsunami”
